Day Three: Thursday, January 18, 2006

Morning Plenary Keynote Session 

8:15am Pharmaceutical Leaders’ Breakfast

9:00 Chairperson’s Review of Day Two 

9:15 Breakout Report out Session – INTERACTIVE PANEL 
The chairperson from each of the breakout sessions will sit on a panel and present a short summary of their discussion. A moderator will then open a discussion amongst all attendees addressing the most critical questions facing the industry.
Moderator: Phillips Kuhl, President, Cambridge Healthtech Institute

10:00 Presentation Title to be Determined
Mark Murcko, Ph.D., Chief Technology Officer & Chair of the Scientific Advisory Board, Vertex Pharmaceuticals

10:45 Networking Coffee Break

11:15 New Approaches to Increasing Productivity in Research and Development
Joanne Killinger, Ph.D., D.A.B.T., Senior Vice President, Drug Safety and Metabolism, Wyeth Pharmaceuticals, Inc.

12:00 Driving Results Through Simplified Innovation
In today's marketplace, finding better ways to foster productivity and boost efficiency in the research and development (R&D) process drives a company’s long-term success.

Building from a 70-year history of service to the hospital industry, Hospira is a specialty pharmaceutical and medication delivery company created from the core global hospital products business of Abbott Laboratories. At inception, the company’s goal was revitalizing its pipeline and driving growth through increased R & D investment. The outcome? Implementation of a stage-gate and portfolio management approach, bolstering Hospira's ability to get new products to customers faster and building a sustainable pipeline of products, while also supporting risk-management efforts. Both large and small companies can
adapt these best-in-class practices. 

Christopher B. Begley, MBA, Chief Executive Officer, Hospira, Inc. (formerly Abbott Laboratories Hospital Products Business)

2:00 Close of Executive Summit